Effectiveness of Varenicline: Testing Individual Differences

Completed · Phase 4 · Has a placebo group

Conditions studied: Smoking Addiction

In brief

The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 weeks.

Key facts

Study ID

NCT01228175

Run by

The Mind Research Network

People needed

218

Starts

2010-03-01

Expected to finish

2016-03-01

Last updated by the study team

2018-05-09

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 yrs to 55 yrs
• smoker

You may not qualify if…

• Medical Contraindications

Where it is running

• The Mind Research Network — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.